ChILD-EU registry for childhood lung disease samples
Part of Blood & lymphatic, Genetic & congenital, Lungs & breathing clinical trials.
This trial builds a European “registry and biobank” of children with suspected or confirmed interstitial lung disease (a type of lung problem), as well as conditions that can look similar. It helps researchers learn more about these rare childhood lung diseases and connect families to future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a child (the study focuses on childhood cases).
- Have suspected or confirmed interstitial lung disease (lung tissue inflammation/scarring).
- Or have a condition that can look like interstitial lung disease (a “masquerader”).
- Or have a rare, localized lung disease affecting specific areas of lung tissue.
- Be willing to be part of a long-term research registry and provide/allow stored biological samples (as explained by the study team).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from adults with interstitial lung disease (ILD) who are seeking care at the UPMC Simmons Center. It helps the center learn about ILD and improve future treatment planning.
This trial is a study database that collects information from adults who have other illnesses that can increase the risk of developing interstitial lung disease (lung scarring). It may help researchers better understand who is at risk and how outcomes change over time.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This study collects information from children and teens (up to age 16) who are seen in a children’s lung clinic for breathing or respiratory problems in Switzerland. The goal is to better understand these conditions in everyday care, which may help improve future diagnosis and treatment.
This study looks at severe lung disease in children. It may help doctors better understand and treat these conditions.
This study builds a registry of children with eosinophilic gastrointestinal (gut) disorders (EGIDs) and also includes children being evaluated for possible EGIDs. It may help doctors better understand these conditions and improve future care.
Hear when a new Pulmonary Alveolar Proteinosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.